Summary of findings from the evaluation of a pilot medically supervised safer injecting facility

被引:130
|
作者
Wood, Evan
Tyndall, Mark W.
Montaner, Julio S.
Kerr, Thomas
机构
[1] St Pauls Hosp, British Columbia Ctr Excellence HIV AIDS, Vancouver, BC V6Z 1Y6, Canada
[2] Univ British Columbia, Fac Med, Dept Med, Vancouver, BC, Canada
关键词
D O I
10.1503/cmaj.060863
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In many cities, infectious disease and overdose epidemics are occurring among illicit injection drug users (IDUs). To reduce these concerns, Vancouver opened a supervised safer injecting facility in September 2003. Within the facility, people inject pre-obtained illicit drugs under the supervision of medical staff. The program was granted a legal exemption by the Canadian government on the condition that a 3-year scientific evaluation of its impacts be conducted. In this review, we summarize the findings from evaluations in those 3 years, including characteristics of IDUs at the facility, public injection drug use and publicly discarded syringes, HIV risk behaviour, use of addiction treatment services and other community resources, and drug-related crime rates. Vancouver's safer injecting facility has been associated with an array of community and public health benefits without evidence of adverse impacts. These findings should be useful to other cities considering supervised injecting facilities and to governments considering regulating their use.
引用
收藏
页码:1399 / 1404
页数:6
相关论文
共 50 条
  • [1] Safer injecting education for HIV prevention within a medically supervised safer injecting facility
    Wood, E
    Tyndall, MW
    Stoltz, JA
    Small, W
    Zhang, R
    O'Connell, J
    Montaner, JSG
    Kerr, T
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2005, 16 (04) : 281 - 284
  • [2] Changes in injecting practices associated with the use of a medically supervised safer injection facility
    Stoltz, Jo-Anne
    Wood, Evan
    Small, Will
    Li, Kathy
    Tyndall, Mark
    Montaner, Julio
    Kerr, Thomas
    JOURNAL OF PUBLIC HEALTH, 2007, 29 (01) : 35 - 39
  • [3] Factors Associated with Syringe Sharing Among Users of a Medically Supervised Safer Injecting Facility
    Wood, Evan
    Tyndall, Mark W.
    Stoltz, Jo-Anne
    Small, Will
    Lloyd-Smith, Elisa
    Zhang, Ruth
    Montaner, Julio S. G.
    Kerr, Thomas
    AMERICAN JOURNAL OF INFECTIOUS DISEASES, 2005, 1 (01) : 50 - 54
  • [4] Rationale for evaluating North America's first medically supervised safer-injecting facility
    Wood, E
    Kerr, T
    Montaner, JS
    Strathdee, SA
    Wodak, A
    Hankins, CA
    Schechter, MT
    Tyndall, MW
    LANCET INFECTIOUS DISEASES, 2004, 4 (05): : 301 - 306
  • [5] Impact of a medically supervised safer injecting facility on drug dealing and other drug-related crime
    Wood, Evan
    Tyndall, Mark W.
    Lai, Calvin
    Montaner, Julio S. G.
    Kerr, Thomas
    SUBSTANCE ABUSE TREATMENT PREVENTION AND POLICY, 2006, 1 (1)
  • [6] Impact of a medically supervised safer injecting facility on drug dealing and other drug-related crime
    Evan Wood
    Mark W Tyndall
    Calvin Lai
    Julio SG Montaner
    Thomas Kerr
    Substance Abuse Treatment, Prevention, and Policy, 1
  • [7] Changes in public order after the opening of a medically supervised safer injecting facility for illicit injection drug users
    Wood, E
    Kerr, T
    Small, W
    Li, K
    Marsh, DC
    Montaner, JSG
    Tyndall, MW
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2004, 171 (07) : 731 - 734
  • [8] Injection drug use cessation and use of North America's first medically supervised safer injecting facility
    DeBeck, Kora
    Kerr, Thomas
    Bird, Lorna
    Zhang, Ruth
    Marsh, David
    Tyndall, Mark
    Montaner, Julio
    Wood, Evan
    DRUG AND ALCOHOL DEPENDENCE, 2011, 113 (2-3) : 172 - 176
  • [9] Employment among users of a medically supervised safer injection facility
    Richardson, Lindsey
    Wood, Evan
    Zhang, Ruth
    Montaner, Julio
    Tyndall, Mark
    Kerr, Thomas
    AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2008, 34 (05): : 519 - 525
  • [10] Initial experience with subcutaneous depot buprenorphine in a medically supervised injecting facility
    Weeks, Anthony
    Cogger, Shelley
    Clark, Nico
    DRUG AND ALCOHOL REVIEW, 2021, 40 (07) : 1354 - 1355